HSV-1 gD Antibodies

Santa Cruz Biotechnology features a diverse variety of HSV-1 gD monoclonal antibodies for research focused on understanding glycoprotein D in herpes simplex virus type 1. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glycoprotein D is a critical component of the HSV-1 envelope, playing a vital role in viral entry and infection by mediating the interaction between the virus and host cell receptors. Understanding HSV-1 gD function is essential for developing therapeutic strategies and vaccines against herpes simplex virus infections. Research on HSV-1 gD reveals important insights into viral pathogenesis and immune evasion mechanisms. HSV-1 gD monoclonal antibodies enable precise detection and characterization of viral proteins during infection stages. Investigating HSV-1 gD expression patterns helps identify potential therapeutic targets and vaccine candidates. Advanced research techniques using HSV-1 gD monoclonal antibodies support breakthrough discoveries in viral research and therapeutic development. Santa Cruz Biotechnology monoclonal antibodies for HSV-1 gD research continue advancing scientific understanding of viral infections and supporting development of new treatment strategies.